-
公开(公告)号:US20140113970A1
公开(公告)日:2014-04-24
申请号:US13657711
申请日:2012-10-22
IPC分类号: A61M35/00 , A61K31/196
CPC分类号: A61K31/196 , A61K9/0014 , A61K9/06 , A61K9/08 , A61K47/38 , A61M35/003
摘要: The invention provides systems and methods for controlled dispensing of topical analgesics contained in a metered dispensing system. The systems and method are useful for treating signs and symptoms of osteoarthritis. The method includes depressing a hand pump to dispense a dose of a topical pain reliever in a viscous solution from the hand pump, wherein the hand pump is configured to dispense the dose within a tolerance specified by a corresponding label approved by a government regulatory agency; and spreading the topical solution on skin.
摘要翻译: 本发明提供了用于受控分配包含在计量分配系统中的局部止痛剂的系统和方法。 该系统和方法可用于治疗骨关节炎的体征和症状。 该方法包括按压手泵以将来自手动泵的粘性溶液中的一定剂量的局部止痛剂分配到其中,其中手动泵配置为在由政府监管机构批准的对应标签指定的容限内分配剂量; 并将局部溶液涂抹在皮肤上。
-
公开(公告)号:US09308181B2
公开(公告)日:2016-04-12
申请号:US13791460
申请日:2013-03-08
申请人: Nuvo Research Inc.
发明人: Edward T. Kisak , John M. Newsam , Dominic King-Smith , Pankaj Karande , Samir Mitragotri , Tejas Desai , Wade A. Hull
IPC分类号: A61K31/196 , A61K31/405 , A61K9/70 , A61K31/192 , A61K31/40 , A61K31/407 , A61K31/5415 , A61K47/14 , A61K31/19 , A61K31/195 , A61K31/444 , A61K9/00 , A61K9/06 , A61F7/03 , A61K47/12 , A61K47/18 , A61K47/20 , A61K45/06 , A61K31/568 , A61K31/137 , A61K31/167 , A61K31/245 , A61F7/02
CPC分类号: A61K9/703 , A61F7/03 , A61F2007/0261 , A61K9/0014 , A61K9/06 , A61K9/7084 , A61K31/137 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/195 , A61K31/196 , A61K31/245 , A61K31/40 , A61K31/405 , A61K31/407 , A61K31/444 , A61K31/5415 , A61K31/568 , A61K45/06 , A61K47/12 , A61K47/14 , A61K47/183 , A61K47/20 , A61K2300/00
摘要: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
摘要翻译: 本公开内容涉及局部制剂,透皮系统和相关方法。 在一个实施方案中,提供了包括局部麻醉剂,第一化合物和第二化合物的局部制剂。 第一化合物和第二化合物不同,各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US20130337031A1
公开(公告)日:2013-12-19
申请号:US13791460
申请日:2013-03-08
申请人: Nuvo Research Inc.
发明人: Edward T. Kisak , John M. Newsam , Dominic King-Smith , Pankaj Karande , Samir Mitragotri , Tejas Desai , Wade A. Hull
IPC分类号: A61K9/70 , A61K31/405 , A61K31/5415 , A61K31/40 , A61K31/407 , A61K31/196 , A61K31/192
CPC分类号: A61K9/703 , A61F7/03 , A61F2007/0261 , A61K9/0014 , A61K9/06 , A61K9/7084 , A61K31/137 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/195 , A61K31/196 , A61K31/245 , A61K31/40 , A61K31/405 , A61K31/407 , A61K31/444 , A61K31/5415 , A61K31/568 , A61K45/06 , A61K47/12 , A61K47/14 , A61K47/183 , A61K47/20 , A61K2300/00
摘要: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
摘要翻译: 本公开内容涉及局部制剂,透皮系统和相关方法。 在一个实施方案中,提供了包括局部麻醉剂,第一化合物和第二化合物的局部制剂。 第一化合物和第二化合物不同,各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US20160279245A1
公开(公告)日:2016-09-29
申请号:US15033467
申请日:2014-10-31
申请人: NUVO RESEARCH INC.
发明人: Wade Hull , Tejas Desai
IPC分类号: A61K47/20 , A61K31/167 , A61K31/245 , A61K31/196 , A61F7/03 , A61K47/32 , A61K47/26 , A61K47/14 , A61K9/70 , A61K9/00 , A61K31/573
CPC分类号: A61K47/20 , A61F7/03 , A61F2007/0226 , A61F2007/0261 , A61K9/0014 , A61K9/7023 , A61K31/167 , A61K31/196 , A61K31/245 , A61K31/573 , A61K47/14 , A61K47/26 , A61K47/32 , A61K2300/00
摘要: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a drug such as a local anesthetic, an NSAID, or a corticosteriod; and sodium lauryl sulfoacetate. The topical formulations can have enhanced physical and/or chemical stability as compared to similar formulations without sodium lauryl sulfoacetate.
摘要翻译: 本公开内容涉及局部制剂,透皮系统和相关方法。 在一个实施方案中,提供了包括药物如局部麻醉剂,NSAID或皮质类固醇的局部制剂; 和月桂基磺基乙酸钠。 与不含月桂基磺基乙酸钠的类似制剂相比,局部制剂可以具有增强的物理和/或化学稳定性。
-
-
-